Skip to main content

Table 1 Eleven microarray-based miRNA expression profiling studies of human PDAC tissues

From: Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance

First author (reference) Acronym Region Assay type No. of probes No. of samples (cancer/normal)
AE Szafranska [21] AE USA Custom microarray 377 13 (8/5)
Ada Piepoli [22] AP Italy Affymetrix GeneChip array 866 NR (cancer=17)
Andrea S.Bauer [23] AS Germany Geniom biochip miRNA homo sapiens NR 110 (94/16)
Eun Joo Lee [24] EJ USA Agilent Human miRNA Microarray NR 28 (15/13)
Mark Bloomston [25] MB USA Custom miRNA microarray 1100 130 (65/65), 65 pairs
Nicolai A.Schultz [26] NA Denmark TaqMan array human microRNA A+B Cards v2.0 664 188 (160/28)
Nigel B.Jamieson [27] NB USA Agilent Human miRNA Microarray (version 2.0) 723 58 (48/10)
Nicole C.Panarelli [28] NC USA FlexmiR miRNA microarray 328 27 (17/10)
S Ali [29] SA USA LC Science Houston microarray NR 44 (29/15)
Shuyu Zhang [30] SZ China Exiqon miRCURY LNA array 1200 40 (20/20), 20 pairs
Yuichi Nagao [31] YN Japan Toray 3D-Gene miRNA microarray >900 79 (65/24)
  1. Abbreviations: NR not reported, pairs, cancerous and normal samples from the same patient.